skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Vasohibin prevents arterial neointimal formation through angiogenesis inhibition

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1];  [1];  [1];  [2];  [3];  [3];  [4];  [4];  [1]
  1. Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai (Japan)
  2. Department of Pathology, Tohoku University Hospital, Sendai (Japan)
  3. Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, Sendai (Japan)
  4. Diagnostics Science Division, Shionogi and Co. Ltd, Osaka 561-0825 (Japan)

Vasohibin is a VEGF-inducible angiogenesis inhibitor in vascular endothelium. Here we examined the presence of vasohibin in human arterial wall, and found it in endothelium of adventitial microvessels in atherosclerotic lesion. Adventitial angiogenesis is involved in the progression of neointimal formation. Even in the presence of endogenous angiogenesis inhibitors, pathological angiogenesis persists. However, the supplementation of exogenous angiogenesis inhibitors can prevent pathological angiogenesis. We evaluated the potential role of vasohibin in neointimal formation. Adenovirus-mediated human vasohibin gene transfer in mouse liver resulted in the release of vasohibin in plasma and exhibited anti-angiogenic effects at remote sites. This gene transfer inhibited adventitial angiogenesis, macrophage infiltration, and neointimal formation after cuff placement on mouse femoral artery. Vasohibin exhibited no direct effect on migration and proliferation of smooth muscle cells. Thus, vasohibin has an activity to prevent neointimal formation by inhibiting adventitial angiogenesis.

OSTI ID:
20854333
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 345, Issue 3; Other Information: DOI: 10.1016/j.bbrc.2006.04.176; PII: S0006-291X(06)01021-7; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer
Journal Article · Mon Oct 01 00:00:00 EDT 2012 · Toxicology and Applied Pharmacology · OSTI ID:20854333

A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo
Journal Article · Fri Jan 06 00:00:00 EST 2012 · Biochemical and Biophysical Research Communications · OSTI ID:20854333

Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells
Journal Article · Mon Dec 15 00:00:00 EST 2014 · Toxicology and Applied Pharmacology · OSTI ID:20854333